ask="N/A"
ask_size="N/A"
average_daily_volume="21213"
bid="N/A"
bid_size="N/A"
book_value="0.45"
change="+0.15"
change_from_200_day_moving_average="0.26"
change_from_50_day_moving_average="0.23"
change_from_52_week_high="-1.19"
change_From_52_week_low="2.24"
change_in_percent="+3.80%"
close="4.10"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.44"
ebitda="-14.69M"
eps_estimate_current_year="-1.69"
eps_estimate_next_quarter="-0.02"
eps_estimate_next_year="-0.25"
ex_dividend_date="N/A"
float_shares="4889000"
high="4.10"
high_52_weeks="5.29"
last_trade_date="3/1/2017"
last_trade_price="4.10"
last_trade_size="100"
last_trade_time="4:02pm"
low="3.80"
low_52_weeks="1.86"
market_capitalization="62.05M"
moving_average_200_day="3.84"
moving_average_50_day="3.87"
name="NovaBay Pharmaceuticals
Inc. C"
notes="N/A"
one_year_target_price="6.75"
open="3.90"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+6.88%"
percent_change_from_50_day_moving_average="+5.89%"
percent_change_from_52_week_high="-22.50%"
percent_change_from_52_week_low="+120.44%"
previous_close="3.95"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="8.74"
price_per_sales="6.32"
revenue="9.45M"
shares_outstanding="15134000"
short_ratio="6.33"
stock_exchange="ASE"
symbol="NBY"
volume="10129"
weeks_range_52="1.86 - 5.29"
